MedPath

Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases

Phase 3
Completed
Conditions
Gastric Diseases,
Gastric Ulcer,
Early Gastric Cancer,
Chronic Gastritis
Gastric Polyps,
Interventions
Device: MCE
Device: Standard gastroscopy
Registration Number
NCT02219529
Lead Sponsor
Changhai Hospital
Brief Summary

A new Magnetic-controlled Capsule Endoscopy (MCE) was developed by ANKON and got SFDA's approval in China in 2013. It has recently been evaluated to compare the diagnostic accuracy of MCE with that of standard gastroscopy for gastric diseases in 70 patients with encouraging results (In Press). To further testify the diagnostic accuracy of MCE for both the diffuse and focal diseases in stomach, we performed this single-blinded multi-center prospective study compared MCE with gastroscopy in patients with gastric symptoms and indication for upper GI Endoscopy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
350
Inclusion Criteria
  • Patients presented with gastric symptoms and ready for the first Upper GI endoscopy
  • Patients with known focal gastric diseases: gastric ulcer, gastric polyps, early gastric cancer, gastric stromal tumors and so on.
  • Age of 18 years to 70 years
Exclusion Criteria
  • Patients with impaired bowel movement from ileus or organic digestive diseases
  • Patients with known large and obstructing tumors of the upper GI tract
  • Patients after upper GI surgery or abdominal surgery altering GI anatomy
  • Patients under full anticoagulation
  • Patient in poor general condition
  • Patients using equipment that may be affected by radio transmission
  • Patients using equipment that may be affected by magnetic field
  • Pregnancy or suspected pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MCEMCEpatients were assigned to swallow MCE first, followed by the gastroscopy
Standard gastroscopyStandard gastroscopypatients were assigned to swallow MCE first, followed by the gastroscopy
Primary Outcome Measures
NameTimeMethod
Number of subjects diagnosed with gastric diffuse lesions by MCE Versus Standard Gastroscopy2 days
Number of gastric focal lesions founded by MCE Versus Standard Gastroscopy2 days
Secondary Outcome Measures
NameTimeMethod
Volume of water and drugs used for gastric preparation1 hour
Scores of the cleanliness of stomach after preparation1 day
Percentage of patients in whom there was complete visualization of the gastric surface in the antrum, body, and fundus and identification of the cardia and pylorus1 day
Examination times of MCE and standard gastroscopy1 day
Patient acceptance of MCE and standard gastroscopy3 days
Adverse events of both procedures2 weeks

Trial Locations

Locations (1)

Shanghai Changhai Hospital

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath